Skip to main content
. 2023 Aug 23;16:3619–3630. doi: 10.2147/JIR.S418106

Table 4.

Multivariate Logistic Regression Analysis According to Quartiles of NLR, PLR, LMR, and SIRI

Clinical Outcome NLR P values
Q1 (<1.96) N=214 Q2 (1.96–2.63) N=216 Q3 (2.64–3.99) N=215 Q4 (≥4.00) n=216
Poor functional outcome
Cases, n (%) 25(11.7%) 41(19.0%) 52(24.2%) 76(35.2%) P<0.001
Model 1 1.00 1.538(0.841–2.812) 2.269(1.273–4.047) 2.607(1.463–4.644)
Model 2 1.00 1.463(0.795–2.694) 2.197(1.227–3.934) 2.495(1.394–4.466)
PLR
Clinical outcome Q1 (<103.19) N=215 Q2 (103.19–134.96) N=215 Q3 (134.97–180.92) N=216 Q4 (≥180.93) n=215
Poor functional outcome
Cases, n (%) 35(16.3%) 44(20.5%) 52(24.1%) 63(29.3%) P=0.010
Model 1 1.00 1.429(0.820–2.492) 1.706(0.975–2.985) 1.962(1.149–3.351)
Model 2 1.00 1.421(0.811–2.491) 1.694(0.963–2.980) 1.959(1.138–3.373)
LMR
Clinical outcome Q1 (<2.90) N=213 Q2 (2.90–3.79) N=209 Q3 (3.80–4.99) N=198 Q4 (≥5.00) n=241
Poor functional outcome
Cases, n (%) 73(34.3%) 48(23.0%) 41(20.7%) 32(13.3%) P<0.001
Model 1 2.384(1.386–4.098) 1.651(0.946–2.882) 1.607(0.912–2.833) 1.00
Model 2 2.300(1.331–3.975) 1.539(0.876–2.704) 1.509(0.850–2.679) 1.00
SIRI
Clinical outcome Q1 (<0.77) N=214 Q2 (0.77–1.11) N=213 Q3 (1.12–1.79) N=214 Q4 (≥1.80) n=220
Poor functional outcome
Cases, n (%) 35(16.4%) 28(13.1%) 49(22.9%) 82(37.3%) P<0.001
Model 1 1.00 0.730(0.401–1.331) 1.359(0.791–2.337) 1.932(1.150–3.248)
Model 2 1.00 0.682(0.372–1.251) 1.304(0.754–2.255) 1.866(1.106–3.146)

Notes: Model 1: adjusted for age, sex, length of hospital stay, NIHSS score at admission, TOAST classification and stroke history.Model 2: further adjusted for TG, smoking, drinking, medical history (hypertension, diabetes, atrial fibrillation), thrombolysis and glucose-lowering drugs.

Abbreviations: NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; LMR, lymphocyte-monocyte ratio; SIRI, systemic inflammation response index; NIHSS, National Institute of Health Stroke Scale; TG triglyceride.